Science By screening hundreds of sybodies (synthetic mini-antibodies), scientists have identified one that might stop SARS-CoV-2 from infecting human cells. This work, which holds promise for treating COVID-19, was conducted by EMBL Hamburg and collaborators from the Centre for Structural Systems Biology…
2020
science
Science Scientists hope that a legacy of the novel coronavirus in recovered COVID-19 patients – antibodies in their blood – could lead to drugs to treat others. The Merten group at EMBL Heidelberg has pivoted its microfluidics platform to support the search for neutralising antibodies that could…
2020
science
Lab Matters New EMBL spinoff company Velabs Therapeutics aims to speed up discovery of therapeutic antibodies
2018
lab-matters
No matching posts found
Looking for past print editions of EMBLetc.? Browse our archive, going back 20 years.
EMBLetc. archive